Scholar Rock Holding (SRRK) Receivables - Net (2019)

Scholar Rock Holding's (SRRK) quarterly Receivables - Net came in at $25.0 million in Q4 2019.

Scholar Rock Holding (SRRK) Receivables - Net (2019) Analysis & Trends

Scholar Rock Holding's Receivables - Net history runs 1 years deep, the most recent figure standing at $25.0 million for Q4 2019.

On a quarterly basis, Receivables - Net changed N/A year-over-year to $25.0 million in Q4 2019; TTM through Dec 2019 was $25.0 million, a N/A change from a year earlier, with the FY2019 full-year figure at $25.0 million, changed N/A from the prior year.
Receivables - Net held at $25.0 million in Q4 2019 per SRRK's latest filing.
Across five years, Receivables - Net topped out at $25.0 million in Q4 2019 and bottomed at $25.0 million in Q4 2019.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Scholar Rock Holding	6.30 Bn	6.30 Bn	-

Historic Data

Download Data

Date	Value
Dec 31, 2019	25.00 Mn
Dec 31, 2019	25.00 Mn